likely to recommend evidence-based guideline-supported interventions." There is a call for physician attention to local factors that influence physicians' clinical judgment aside from following evidence-based diagnostic and treatment guidelines. [5] Our experiences have shown that evidence-based guidelines in cardiovascular care have lagged behind numerous scientific publications that link adverse cardiovascular consequences in undiagnosed and untreated SDB such as obstructive sleep apnea-hypopnea (OSAH), sleep movement disorders such as periodic limb movement disorders, and insomnia. [6] Studies have shown that OSAH leads up to 300%-400% higher risk of heart attack, stroke, or death than those without OSAH. The predisposing causes of deadly cardiovascular events that lead to hospitalizations and invasive cardiac procedures such as hypertension, diabetes, diastolic dysfunction, systolic heart failure, pulmonary arterial hypertension, obesity, and cardiac arrhythmias to name have been clearly linked in cause-and-effect relationships to OSAH. Yet, the presence of OSAH in a cardiac patient is not in the radar screen of treating cardiologists in terms of at least taking a brief history to assess the presence or absence of OSAH. [3, [7] [8] [9] Pharmacotherapies between the CC and CSM groups were similar. Almost all patients were treated with antiplatelet inhibitors, statins, angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers, and beta-blockers, when applicable. In 2004-2013, the Food and Drug Administration-approved omega 3 fatty acids, namely docosahexaenoic acid and eicosapentaenoic acid (EPA) were added; ACEIs were changed to angiotensin release blockers for better tolerability; propranolol and metoprolol were transitioned to carvedilol; and pravastatin and simvastatin to mainly atorvastatin and rosuvastatin, respectively. [10] [11] [12] [13] 
results
We noted substantial reductions of ERV, HA, CICUA, and ICS during the years when Chanwell Clinic transitioned to the CSM model [ Table 1 ]. A single CC practice that transitions to ICSM resulted in over $21 million or 73% reduction of CV health care over a 10-year period. Diagnosis and treatment of SDB, OSAH common in CVD, has produced a marked reduction of ERV, HA, CICUA, and ICS; all are drivers of an ever-escalating financial burden of CV care [ Figures 1 and 2 , Table 2 ].
We took into account the cost of sleep medicine care in terms of sleep diagnosis and treatment with continuous positive airway pressure (CPAP) and supplies. CSM model results in 73% reductions in health-care cost over a 10-year period [ Table 3 and Figure 3 ]. (1994-2003) . [14] [15] [16] Nonetheless, even with such advances in pharmacotherapeutics in the CSM model, we have to conclude that early diagnosis and treatment of OSAH in the CSM accounted for the huge gains in reductions of ERV, CICUA, ICS, and its associated costs.
Assuming a hypothetical conversion of standard of CC to the model integrated with sleep medicine (CSM), the projected 10-year CV spent of $1.7 trillion could be reduced to $500 billion. Nonetheless, even a 25% conversion to CSM on 27,000 cardiologists and cardiology practices nationwide could drastically slow down the rising cost of health care even with the enactment of Affordable Care Act and could make Medicare sustainable over a longer period beyond 2029; the year when Medicare is projected to be insolvent (Congressional Research Service, July 2013).
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The study did not take into account the role of OSAH in the genesis of cancer deaths and the cost savings of future reductions of oncology care expenditures in a CSM model. [17, 18] The study also did not take into account the 2014 Medicare establishment of competitive bidding that resulted in almost 50% reductions in payment to durable medical equipment companies of CPAP and bilevel positive airway pressure sleep supplies, thus driving down CSM cost further.
conclusion
A single CC practice that transitions to ICSM resulted in over $21 million or 73% reduction of CV health-care cost over a 10-year period. The ICSM practice model when implemented
